BDBM317604 US9624199, 14::{6-[(1-Methoxybutan-2-yl)amino]pyridin-3-yl}[(3R)-3-methyl-1,4′-bipiperidin-1′-yl]methanone
SMILES: CCC(COC)Nc1ccc(cn1)C(=O)N1CCC(CC1)N1CCC[C@@H](C)C1
InChI Key: InChIKey=MVHLBLFCGGJBTH-DUSLRRAJSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha-1A adrenergic receptor (Homo sapiens (Human)) | BDBM317604 (US9624199, 14 | {6-[(1-Methoxybutan-2-yl)amino]pyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep... | US Patent US9624199 (2017) BindingDB Entry DOI: 10.7270/Q2ZG6VB7 | |||||||||||
More data for this Ligand-Target Pair |